PDS Biotechnology Corporation PDSB

$ 5.91 -5.29%

Quarterly report 2024-Q3
added 11-14-2024

PDS Biotechnology Corporation Balance Sheet 2011-2024 | PDSB

Annual Balance Sheet PDS Biotechnology Corporation

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-73.4 M	-64.8 M	-28.2 M	-12.2 M	-34.6 M	-67.6 M	-91.4 M	-125 M	-10.9 M	-7.86 M	-	-
Long Term Debt	123 K	164 K	231 K	-	-	-	17.4 M	15 M	3.03 M	2.53 M	-	-	-
Long Term Debt Current	-	231 K	259 K	120 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	490 K	-	-	17.4 M	15 M	3.03 M	41 M	22.3 M	-	-
Total Current Liabilities	13.6 M	9.82 M	3.76 M	3.27 M	2.79 M	6.38 M	12.9 M	6.68 M	8.59 M	-	-	-	-
Total Liabilities	33.3 M	33 M	3.99 M	3.76 M	2.79 M	6.38 M	30.2 M	21.6 M	11.6 M	44.9 M	24.1 M	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-145 M	-102 M	-60.7 M	-43.8 M	-28.9 M	-193 M	-152 M	-101 M	-62.3 M	-29.8 M	-16 M	-	-
Total Assets	59.4 M	77 M	67.2 M	30.9 M	14.5 M	36.2 M	92.6 M	111 M	134 M	17 M	8.73 M	-	-
Cash and Cash Equivalents	56.6 M	73.8 M	65.2 M	28.8 M	12.2 M	34.6 M	88.1 M	106 M	130 M	13.7 M	7.86 M	-	-
Book Value	26.1 M	44 M	63.2 M	27.1 M	11.7 M	29.8 M	62.4 M	89.3 M	122 M	-27.8 M	-15.3 M	-	-
Total Shareholders Equity	26.1 M	44 M	63.2 M	27.1 M	11.7 M	-2.07 M	62.4 M	89.3 M	122 M	-27.8 M	-15.3 M	-	-

All numbers in USD currency

Quarterly Balance Sheet PDS Biotechnology Corporation

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	77.7 K	93.1 K	108 K	123 K	137 K	152 K	165 K	164 K	77.1 K	59.6 K	147 K	231 K	314 K	395 K	458 K	490 K	490 K	490 K	490 K	-	-	-	903 K	-	-	-	-	-	-	-	-	-	15 M	4.36 M	4.92 M	5.47 M	6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	30.4 M	29.6 M	31.8 M	33.3 M	32.7 M	31.3 M	27.4 M	33 M	27.8 M	4.58 M	5.17 M	3.99 M	3.89 M	4.4 M	3.39 M	3.76 M	3.76 M	3.76 M	3.76 M	2.79 M	-	-	2.79 M	2.23 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-174 M	-163 M	-155 M	-145 M	-134 M	-123 M	-111 M	-102 M	-82.4 M	-75 M	-69.2 M	-60.7 M	-54.4 M	-47.4 M	-46.8 M	-43.8 M	-43.8 M	-43.8 M	-43.8 M	-28.9 M	-28.9 M	-28.9 M	-28.9 M	-21.9 M	-21 M	-21 M	-21 M	-152 M	-152 M	-152 M	-152 M	-101 M	-101 M	-101 M	-101 M	-62.3 M	-62.3 M	-62.3 M	-62.3 M	-29.8 M	-29.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	52.5 M	60.5 M	69 M	59.4 M	57.2 M	63.8 M	68.4 M	77 M	74.9 M	56 M	61 M	67.2 M	71.7 M	77.4 M	27.8 M	30.9 M	30.9 M	30.9 M	30.9 M	14.5 M	14.5 M	14.5 M	14.5 M	164 K	344 K	344 K	344 K	92.6 M	92.6 M	92.6 M	92.6 M	111 M	111 M	111 M	111 M	134 M	134 M	134 M	134 M	16.8 M	17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	49.8 M	57.7 M	66.6 M	56.6 M	54.3 M	60.6 M	65.2 M	73.8 M	71.6 M	53 M	58.9 M	65.2 M	69.7 M	74.7 M	25 M	28.8 M	28.8 M	28.8 M	28.8 M	12.2 M	12.2 M	12.2 M	12.2 M	104 K	104 K	104 K	104 K	88.1 M	88.1 M	88.1 M	88.1 M	106 M	106 M	106 M	106 M	130 M	130 M	130 M	130 M	13.7 M	13.7 M	-	-	7.86 M	-	-	-	-	-	-	-	141 K	-	-	-
Book Value	22 M	30.9 M	37.2 M	26.1 M	24.5 M	32.4 M	41 M	44 M	47.1 M	51.4 M	55.9 M	63.2 M	67.9 M	73 M	24.4 M	27.1 M	27.1 M	27.1 M	27.1 M	11.7 M	14.5 M	14.5 M	11.7 M	-2.07 M	344 K	344 K	344 K	92.6 M	92.6 M	92.6 M	92.6 M	111 M	111 M	111 M	111 M	134 M	134 M	134 M	134 M	16.8 M	17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	22 M	30.9 M	37.2 M	26.1 M	24.5 M	32.4 M	41 M	44 M	47.1 M	51.4 M	55.9 M	63.2 M	67.9 M	73 M	24.4 M	27.1 M	27.1 M	27.1 M	27.1 M	11.7 M	11.7 M	11.7 M	11.7 M	-2.07 M	-1.7 M	-1.7 M	-1.7 M	-610 K	62.4 M	62.4 M	62.4 M	89.3 M	89.3 M	89.3 M	89.3 M	122 M	122 M	122 M	122 M	-27.8 M	-27.8 M	-	-	-15.3 M	-	-	-	-7.65 M	-	-	-	-	-	-	-

All numbers in USD currency